• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Factory CRO and Boston Biomedical Associates Announce Merger

Share:

January 14, 2019

The merger realizes the shared strategic goal of becoming the leading Global Medical Device and Medical Technology Focused CRO

Factory-CRO Group, a leading global contract research organization focused on medical devices and in vitro diagnostics, and Boston Biomedical Associates a premier full-service Medical Device/Biotechnology CRO and Consultancy based in the United States announce that they have merged the organizations.

The merger further advances the shared strategic vision to become the leading Global Medical Device and Medical Technology focused CRO. Following the recent acquisitions of MileStone Research Organization, Five Corners, and Clinical Device Group the Factory-CRO Group now has specialized operations and expertise in the United States, Australia/New Zealand, and Europe. This global expansion coupled with the diverse medical therapeutic expertise provides a means to efficiently service clients.

“BBA is excited to join Factory-CRO’s worldwide group as it will allow us to expand our comprehensive service offering to our clients,” said Lauren Baker, PhD, President and CEO of BBA. “The alignment of Factory-CRO and BBA’s core values and approach to engagements combined with our collective therapeutic competencies ensures that our clients now have improved access to our global clinical trial execution resources, and our regulatory and medical expertise.” Dr. Baker then added, “We are able to fully support our clients as their needs evolve and they strive to help patients globally.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“We are honored to have the BBA team join the Factory-CRO Group,” said Dirk Meijer, MD, MSc,PhD, Factory-CRO CEO. “BBA’s ability to provide CRO/Consultative service in North America was a missing link in our global offerings.” Dr. Meijer then added, “Our clients have consistently asked us to expand our offerings in North America. This merger allows us to provide our specialized expertise and a continued commitment to the highest level of customized service to a larger audience. Now we are the only Medical Device and Medical Technology CRO that offers services in United States, Europe, Australia and New Zealand. We operate from our own offices located within each region housed with employees that have refined expertise to meet our unique client needs.”

Date: January 14, 2019

Source: Factory

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Drug Discovery Services Market to 2027 – Size, Share & Industry Trends Analysis Report | Emergen ResearchDrug Discovery Services Market to 2027 – Size, Share & Industry Trends Analysis Report | Emergen Research
  • Sensus Healthcare Acquires Two Mobile Aesthetic Laser Companies in FloridaSensus Healthcare Acquires Two Mobile Aesthetic Laser Companies in Florida
  • Clearday Inc. Enters Into Agreement With Invento Research Inc. and Schedules DemonstrationClearday Inc. Enters Into Agreement With Invento Research Inc. and Schedules Demonstration
  • Assertio Holdings, Inc. to Acquire Spectrum Pharmaceuticals, Inc. in all Stock and CVR TransactionAssertio Holdings, Inc. to Acquire Spectrum Pharmaceuticals, Inc. in all Stock and CVR Transaction
  • Velocity Clinical Research Begins European Expansion with German Site AcquisitionVelocity Clinical Research Begins European Expansion with German Site Acquisition
  • Mölnlycke acquires patent for smart solutions to detect infection in woundsMölnlycke acquires patent for smart solutions to detect infection in wounds
  • Summit Medical Group Oregon Adds Bend Urology AssociatesSummit Medical Group Oregon Adds Bend Urology Associates
  • Alume Biosciences Completes $5.5M Series A FinancingAlume Biosciences Completes $5.5M Series A Financing

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications